Skip to content
Aju.News
Menu
Korea
World
Technology
Business
Sports
Entertainment
Health
Aju.News
Menu
Korea
World
Technology
Business
Sports
Entertainment
Health
Legdanbimab
Celltrion Corona Treatment Recommended for Mild Patients in Moderate and High Risk Groups